As everyone is reflecting on the year and looking forward to 2022, we celebrate the best stories, news and milestones.

From postdoctoral and continued medical education to public outreach and scientific publications, THI remains dedicated to spreading awareness and sharing updates on ways to prevent, treat and defeat cardiovascular disease.

With over 12 million visitors to the website from around the world every year, texasheart.org is just one of the ways THI is helping to educate people on the importance of heart health.

The top story celebrates the arrival of THI’s new President and CEO, Dr. Joseph G. Rogers.

To ensure its commitment aligned with the ever-changing environments in which we live and work, THI’s new leadership felt it was time to refresh the mission, vision, and values statements to ensure they reflected the collective future, aspirations, and expectations for the organization. This year’s most popular stories highlight the many advances and contributions to THI’s refreshed mission to deliver the future of cardiovascular health through exceptional patient care, discovery, and a commitment to learning.

As the Texas Heart Institute has grown and evolved over the last sixty years, one thing has never changed – its commitment to excellence. 

Top Stories of 2021

Texas Heart Institute Announces New President and Chief Executive Officer

Texas Heart Institute Presents Paradigm-Shifting Late Breaking Heart Failure Therapy Research at American Heart Association Annual Meeting

Did you know? Surgeons Crowded the Operating Room to Observe New Techniques at THI

Texas Heart Institute at Baylor St. Luke’s Medical Center recognized as Houston’s Highest-Ranked Center for Adult Cardiology & Heart Surgery by U.S. News & World Report

El Texas Heart Institute Inaugura El Texas Heart Medical Group

The Bionic Bride’s Journey Continues with the Texas Heart Institute

Dr. Darren Woodside – Texas Heart Institute Vice President for Research – Receives Heralded Fellow Designation by the National Academy of Inventors

A New Documentary Chronicles the Development of the Permanent Artificial Heart

THI’s New President and CEO Dr. Joseph Rogers Begins His Leadership Tenure

Groundbreaking Cardiovascular Gene Therapy Has Potential to Drastically Alter Outlook for Heart Failure Patients

Dr. O.H. Frazier Receives 2021 AATS Scientific Achievement Award

Could a Simple Pill Make Vaccines Work Better?

Meet Michael Magarakis AATS 2021 Denton A. Cooley Fellow

Burgeoning Hybrid Atrial Fibrillation Program at THI Bolstered by FDA Approval of Innovative New EPi-Sense Treatment System

Gently Stimulating the Heart to Resolve Deadly Cardiac Arrhythmias

The Future of Cardiovascular Care is Bright: Match Day 2021

In the Spotlight: Texas Heart Institute Perfusion Student to Take Part in Cutting-Edge New Partnership